Nicholas A. Saccomano

Insider Reports History

Location
Boulder, CO
Signature
/s/ Rogan Nunn, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Sponsored

Holdings reported by Nicholas A. Saccomano:

Company Role Class Num Shares Value Price $ Report Date Ownership
OnKure Therapeutics, Inc. President and CEO, Director Class A Common Stock 7,333 $30,479 $4.16 23 Mar 2026 Direct
OnKure Therapeutics, Inc. President and CEO, Director Employee Stock Option (right to buy) 330,000 01 Apr 2026 Direct

Insider Reports Filed by Nicholas A. Saccomano

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OKUR OnKure Therapeutics, Inc. 01 Apr 2026 1 $0 4 President and CEO, Director 03 Apr 2026, 15:29
OKUR OnKure Therapeutics, Inc. 23 Mar 2026 1 -$357 4 President and CEO, Director 24 Mar 2026, 18:57
OKUR OnKure Therapeutics, Inc. 22 Dec 2025 1 -$258 4 President and CEO, Director 23 Dec 2025, 20:09
OKUR OnKure Therapeutics, Inc. 22 Sep 2025 1 -$231 4 President and CEO, Director 24 Sep 2025, 19:42
OKUR OnKure Therapeutics, Inc. 23 Jun 2025 1 -$210 4 President and CEO, Director 25 Jun 2025, 18:52
OKUR OnKure Therapeutics, Inc. 04 Apr 2025 2 -$2,570 4 President and CEO, Director 08 Apr 2025, 17:32
OKUR OnKure Therapeutics, Inc. 27 Jan 2025 1 $0 4 President and CEO, Director 29 Jan 2025, 20:36
OKUR OnKure Therapeutics, Inc. 04 Oct 2024 6 $0 4 President and CEO, Director 08 Oct 2024, 19:29
OKUR OnKure Therapeutics, Inc. 04 Oct 2024 0 $0 3 President and CEO, Director 08 Oct 2024, 19:14

Sponsored